COMMUNIQUÉS West-GlobeNewswire

Aeglea BioTherapeutics Announces Proposed Public Offering of Common Stock
05/02/2019
AUSTIN, Texas, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (Nasdaq:AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare [...]
Rockwell Medical, Inc. to Present at 2019 BIO CEO & Investor Conference
05/02/2019
WIXOM, Mich., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, will present at the 2019 BIO CEO [...]
Sientra Announces miraDry Leadership Transition
05/02/2019
SANTA BARBARA, Calif., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, announced today that it has appointed Kirk Gunhus to the position of General Manager of miraDry, [...]
ReWalk Robotics to Report Fourth Quarter and Year-End 2018 Financial Results on February 8, 2019
05/02/2019
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Feb. 05, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its fourth quarter and year- [...]
Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2018 Financial Results on February 26
05/02/2019
MINNEAPOLIS, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Globus Medical Schedules Fourth Quarter and Full Year 2018 Earnings Release and Conference Call
05/02/2019
AUDUBON, Pa., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31 [...]
AIT Therapeutics Schedules Fiscal Third Quarter 2019 Financial Results Conference Call and Webcast
05/02/2019
Call scheduled for Wednesday, February 13th at 4:30pm Eastern Time. NEW YORK, Feb. 05, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTCQB: AITB), a clinical-stage medical device and biopharmaceutical company focused [...]
aTyr Pharma to Present at the BIO CEO & Investor Conference
05/02/2019
SAN DIEGO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today [...]
Paratek Pharmaceuticals Launches NUZYRA™ (Omadacycline) in the United States
05/02/2019
-- Three Antimicrobial Susceptibility Tests Cleared by FDA for Use with NUZYRA -- -- Launches KEYSTONE TM Surveillance Program to Monitor Omadacycline Susceptibility -- BOSTON, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Paratek [...]
Myriad Genetics Reports Fiscal Second-Quarter 2019 Financial Results
05/02/2019
Total Second-Quarter Revenues of $216.8 Million, Up 15 Percent Second-Quarter Diluted EPS of $0.03 and Adjusted EPS of $0.38, Up 6 Percent SALT LAKE CITY, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ [...]
Emblem Corp. Announces Receipt of Interim Court Order and Mailing of Meeting Materials Related to its Special Meeting of Shareholders and Proposed Arrangement with Aleafia Health Inc.
05/02/2019
TORONTO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“ Emblem ” or the “ Company ”) announces that the Ontario Superior Court of Justice (Commercial List) granted the Company’s motion for [...]
Cerner Reports Fourth Quarter and Full Year 2018 Results and Announces Plan to Initiate Quarterly Cash Dividend
05/02/2019
Fourth Quarter Bookings 2nd Highest in Cerner History KANSAS CITY, Mo., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN) today announced results for the 2018 fourth quarter and full year that ended [...]
Amicus Therapeutics Announces Positive data in Pompe Disease Phase 1/2 Study for Up to 24 Months at 15th Annual WORLDSymposium™
05/02/2019
Consistent and Durable Responses Across Key Measures of Safety, Functional Outcomes and Biomarkers Continue for both ERT-Naïve and ERT-Switch Patients Patient Reported Outcomes Data Demonstrate Benefits in Activities of [...]
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/02/2019
RADNOR, Pa., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat [...]
Bone Therapeutics SA to present at the Annual Meeting of the Orthopaedic Research Society (ORS)
05/02/2019
Press release Gosselies, Belgium, 5 February 2019, 8pm CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, [...]
Agility Health Announces Corporate Update and Trading Resumption
05/02/2019
HAMILTON, Ontario, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Agility Health, Inc. (TSXV: AHI) (“ Agility Health ” or “ Company ”) announces that two (2) of the Company’s operating subsidiaries, Ontario Orthotic Lab Inc. (“ [...]
Apellis’ APL-2 Receives Orphan Drug Designation from the FDA for the Treatment of Autoimmune Hemolytic Anemia
05/02/2019
CRESTWOOD, Ky., and WALTHAM, Mass., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Easton Announces Updates on Its $2,600,000 Framing Contract to Construct 150 Homes as Well as Other Initiatives
05/02/2019
Toronto, ON, Feb. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH ) Provides Operational Update on its $2,600,000 CDN framing contract to build approximately 150 homes just [...]
Healthwise Announces Dr. Daniel Meltzer as Chief Medical Officer
05/02/2019
Healthwise today named Dr. Daniel Meltzer to be the next Healthwise CMO BOISE, Idaho, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Healthwise, a leader in evidence-based health education, technology, and services, announced today [...]

Pages